NCT04916093View on ClinicalTrials.gov

Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

June 10, 2020

Study Completion Date

December 15, 2020

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin 50 MG

Galvus 50 mg oral tablets

DRUG

Sitagliptin 100mg

Januvia 100mg oral tablets

DRUG

MetFORMIN 1000 Mg Oral Tablet

Glucophage 1000 mg oral tablets

Trial Locations (1)

61118

Minya University Hospital, Minya

All Listed Sponsors
collaborator

Minia University

OTHER

lead

Beni-Suef University

OTHER

NCT04916093 - Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter